Lemon Balm Extract (Cyracos).

Lemon balm's rosmarinic acid slows the breakdown of GABA, the brain's main calming signal, while valerenic acid from valerian acts on the same GABA system, so the two reinforce a shift toward a relaxed, settled state. This is a classic traditional calming and pre-sleep pairing that appears together across many formulas.

L-theanine nudges GABA and alpha brainwave activity toward a relaxed but alert state, and lemon balm supports GABA tone through the same calming chemistry, so pairing them tends to promote steady composure rather than drowsiness. The two are commonly formulated together in daytime relaxation and focus blends for this reason.

Chamomile's apigenin binds to GABA-A receptors while lemon balm raises available GABA by slowing its breakdown, so both act on the same calming system from different angles. They are a long-standing pairing in relaxation and evening teas and blends.

Passionflower flavonoids act at the GABA-A receptor while standardised lemon balm slows GABA breakdown. The two act at different points of one inhibitory pathway.

Magnesium dampens NMDA channel activity and supports GABA-A function, and glycine adds its own inhibitory signal. That complements the extract's effect on GABA turnover.

Melatonin sets circadian timing through MT1 and MT2 receptors while the extract raises inhibitory tone. Neither competes for the other's target.

Glycine signals through its own inhibitory receptor and lowers core temperature before sleep. It adds a route the extract does not cover.

Apigenin binds the benzodiazepine site of GABA-A as a partial ligand. Paired with slowed GABA catabolism the two reach the same channel from different sides.

Honokiol and magnolol positively modulate GABA-A channels. Because the extract raises GABA availability the calming effect is additive and total load should be considered.

Kavalactones modulate GABA-A and sodium channels, overlapping with the extract's inhibitory effect. The additive calming response is the reason to record the pairing.

5-HTP is the immediate precursor to serotonin and downstream melatonin, a pathway separate from GABA. The pairing covers two independent evening-mood routes rather than doubling one.

Lemon balm constituents inhibit GABA transaminase in vitro, the enzyme that clears GABA, so more of the transmitter stays available at the synapse. Supplemental GABA adds substrate to the same system, though how much of an oral dose reaches the brain is disputed. The pairing rests on shared target biology rather than a combination trial.

Glutamate decarboxylase converts glutamate to GABA and requires pyridoxal-5-phosphate as its cofactor. If lemon balm acts by slowing GABA breakdown, B6 status governs how much GABA is being made in the first place. This is textbook cofactor chemistry, not a tested pairing.

Magnesium acts at the GABA-A receptor complex and blocks the NMDA channel pore, both of which quiet neuronal firing. Lemon balm approaches the same system from the transmitter-availability side. The two are commonly formulated together for evening use on that mechanistic overlap.

Taurine is an agonist at glycine and GABA-A receptors and behaves as an inhibitory amino acid in the central nervous system. Combined with lemon balm the two converge on the same inhibitory tone. Combination data in people is not available.

Tryptophan is the dietary precursor for serotonin and downstream melatonin, a different arm of evening physiology from the GABA route lemon balm engages. Formulators pair them to cover both. Any additive calming effect should be regarded as expected pharmacology rather than a measured outcome.

Hops constituents interact with GABA-A signalling and hops has a long history of pairing with lemon balm and valerian in evening preparations. Additive sedation is the expected direction, which matters most for anyone already taking something sedating. Trials of the specific two-ingredient pair are lacking.

Lavender preparations act on voltage-gated calcium channels in neurons, a route separate from GABA turnover. Combined with lemon balm the effects are expected to add rather than cancel. The caution is the same one that applies to any stacking of calming ingredients.

Ashwagandha withanolides act mainly through the stress-hormone axis, while lemon balm acts on inhibitory neurotransmission. Because the routes differ, blends often carry both. There is no trial of the combination to size the effect.

Rhodiola is generally used for daytime alertness and lemon balm for evening calm, so stacking them in one dose pushes in two directions. Splitting them across the day is the usual formulation answer. This is a practical interaction rather than a measured pharmacological one.

Caffeine blocks adenosine receptors to raise arousal while lemon balm supports the inhibitory side of the system. Taken together the subjective effect of each may be blunted, which is the expected direction from opposing pharmacology rather than a measured result. Some products use lemon balm deliberately to smooth the edge of a caffeine dose, which is a formulation choice rather than a demonstrated interaction.

Bacopa is used over weeks for memory-related support while lemon balm shows its effects acutely on mood and calm measures. Blends carry both to cover acute and cumulative timescales. No combination study defines what the pair does together.

The polyphenols in lemon balm extract, rosmarinic acid among them, bind non-heme iron in the gut lumen and reduce how much is absorbed. This is the same well-described interaction seen with tea and coffee polyphenols. Separating a lemon balm dose from an iron dose by a couple of hours is the standard way around it.

Ascorbate reduces ferric iron to the ferrous form and keeps it soluble, which partly offsets the binding of iron by plant polyphenols. Where a lemon balm preparation is taken near an iron source, vitamin C works in the opposite direction to the polyphenol effect. The chemistry is well described; the net result in any given meal is not fixed.

Both supply catechol-bearing polyphenols that compete for the same phase II conjugation enzymes and the same intestinal efflux routes. Stacking them raises total polyphenol load and can shift how much of either is absorbed intact. The direction of that shift has not been measured for this specific pair.